Area of research
Cognitive Neuroscience · Cellular and Molecular Neuroscience
Research interest
Research focused on Hippocampus and Schizophrenia (object-oriented programming), with related work in Disease, Radioligand, Substantia nigra. Notable publications include 'Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats', 'Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease', and 'Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18 F-BCPP-EF, 11 C-SA-4503, and 11 C-UCB-J'.
Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle <scp>2A</scp> in Early <scp>Drug‐Naive</scp> Parkinson's Disease
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: <sup>18</sup>F-BCPP-EF, <sup>11</sup>C-SA-4503, and <sup>11</sup>C-UCB-J